SGMO: Message Board for Sangamo Therapeutics, Inc. - InvestorVillage

Sangamo Therapeutics, Inc.

  SGMO website

SGMO   /  Message Board

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous 2500 Messages Top of Message List
Go to Msg #  
MSG # SUBJECT TYPE AUTHOR SENTIMENT RECS DATE POSTED
156079 Re: SGMO @AD/PD'21 (3/9-3/14) will be presenting poster for ST-502 - on-target human alphasynuclein repression activity >99% and durability of response GN gomasna 1 3/6/2021 7:34:27 PM
156078 Re: SGMO @AD/PD'21 (3/9-3/14) will be presenting poster for ST-502 - on-target human alphasynuclein repression activity >99% and durability of response GN JBWIN 16 3/6/2021 3:22:32 PM
156077 Re: SGMO @AD/PD'21 (3/9-3/14) will be presenting poster for ST-502 - on-target human alphasynuclein repression activity >99% and durability of response GN Matt 10011 0 3/6/2021 1:30:55 PM
156076 Re: SGMO @AD/PD'21 (3/9-3/14) will be presenting poster for ST-502 - on-target human alphasynuclein repression activity >99% and durability of response GN civic08801 0 3/6/2021 1:09:56 PM
156075 Re: SGMO @AD/PD'21 (3/9-3/14) will be presenting poster for ST-502 - on-target human alphasynuclein repression activity >99% and durability of response GN Matt 10011 1 3/6/2021 9:14:33 AM
156074 Re: SGMO @AD/PD'21 (3/9-3/14) will be presenting poster for ST-502 - on-target human alphasynuclein repression activity >99% and durability of response GN civic08801 0 3/6/2021 8:54:28 AM
156073 $SGMO wednesday $PFE Hemophilia and $SNY Sickle cell GN sangamo 15 3/6/2021 6:43:00 AM
156072 SGMO @AD/PD'21 (3/9-3/14) will be presenting poster for ST-502 - on-target human alphasynuclein repression activity >99% and durability of response GN sangamo 34 3/6/2021 4:12:23 AM
156071 Re: SM on HCW Gene&Cell Therapies Panel Moderated by Former FDA Commissioner Scott Gottlieb 9Mar2021 GN civic08801 0 3/6/2021 2:34:19 AM
156070 Re: AI algorithm for SGMO SP prediction GN nightowl 7 3/6/2021 12:20:33 AM
Previous 2500 Messages Top of Message List
Go to Msg #  








Financial Market Data provided by
.
Loading...